Enhanced Genomics
Genomics platform and drug discovery programs for pharmaceutical partners developing therapies for human diseases
Highlights
- New on EvolcAdded 2026-11-13
About Enhanced Genomics
Enhanced Genomics develops GenLink, a multi-omics platform that analyzes genome folding and integrates data from primary human cell types to identify genes and causal disease biology. The company also runs in-house therapeutic target discovery and development programs, beginning with autoimmune indications.
It works with partners seeking to support or accelerate drug discovery and development. Enhanced Genomics was spun out of laboratories at the Babraham Institute in Cambridge, UK.
Product: GenLink multi-omics platform and in-house therapeutic target discovery and development programs.
Jobs at Enhanced Genomics
Leadership
- Peter Fraser · Co-FounderSource: company website
- Dan Turner · Chief Technology OfficerSource: company website
More biotech & pharma companies
Ensilicated Technologies
Silica-based biomolecule stabilization technology for biopharmaceutical developers seeking to reduce cold-chain dependenceNew on EvolcEnsocell
AI-driven discovery of precision therapies for fibrotic and autoimmune diseases using human biological dataYoung companyEnterobiotix
Clinical-stage microbiome therapeutics developer advancing oral EBX-102-02 for irritable bowel syndrome and seeking licensing partnersEnterprise Therapeutics
Develops investigational medicines for people with cystic fibrosis and other respiratory diseasesEntropix
Enzyme engineering and biomolecule purification technologies for life-science, diagnostics and industrial customersNew on EvolcEpidarex Exeed
Seeds early-stage life science ventures by developing breakthrough therapeutic research into investable assets
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- FramerHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- CookieYesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.